한글목차

세계 맞춤형 어세이 개발 시장의 미래는 유망하며 의료, 생물학, 환경 및 학술 시장에서 기회가 있습니다. 세계 맞춤형 분석법 개발 시장은 2025-2031년 연평균 7.7%의 성장률을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 맞춤 의료 및 표적 치료에 대한 수요 증가, 바이오마커 탐색 및 검증의 진전입니다.

• Lucintel은 유형별로는 분석법 개발이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상하고 있습니다.
• 용도별로는 의료 분야가 가장 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예측됩니다.

맞춤형 분석법 개발 시장에서의 전략적 성장 기회

맞춤형 어세이 개발 시장의 광범위한 응용 분야는 주로 기술 발전과 신흥 시장의 의료 수요의 진화로 인해 몇 가지 전략적 성장 기회를 제공합니다.

• 유전체 및 단백질체학 분석 : 다양한 연구 분야 및 임상 분야에서 맞춤형 유전체 및 단백질체학 분석에 대한 수요가 증가하고 있습니다. 복잡한 생물학적 샘플을 프로파일링할 수 있는 분석법 개발은 질병 메커니즘에 대한 이해를 높이고 개인 맞춤형 치료를 촉진합니다.
• 감염성 질환의 진단: 감염성 질환에 대한 부담이 크기 때문에 신속한 진단 검사 및 맞춤형 분석 시스템 개발이 필요합니다. 감염성 질환 진단에 집중하는 것은 많은 의료 시스템에서 공중 보건과 환자 개개인의 건강에 도움이 될 수 있습니다.
• 의약품 결과: 개인 맞춤형 의료에 대한 관심은 동반진단 약품의 성장 잠재력을 촉진하고 있습니다. 이러한 특수한 분석은 환자가 특정 치료에 어떻게 반응하는지를 판단하는 데 도움을 주어 더 나은 치료 계획과 효능을 지원합니다.
• 환경 분석 : 맞춤형 분석 시장은 독소 및 병원균을 검출하기 위해 경피 분석 및 혈액 분석이 사용되는 환경 검사 동향과 함께 다양화되고 있습니다. 이러한 분석을 통해 오염에 대처함으로써 공중 보건 및 보건법 준수를 촉진할 수 있습니다.
• PoC 분석 : 광범위한 PoC(Point of Care) 솔루션에 대한 필요성이 증가함에 따라 PoC용 맞춤형 분석에 대한 수요가 증가하고 있습니다. 간편하고 비용 효율적인 PoC 대안을 제공함으로써 적시에 검사를 받을 수 있는 환자의 불편함을 줄이고 의료 서비스의 질을 향상시킬 수 있습니다.

이러한 성장 기회는 맞춤형 분석 서비스 시장이 크게 확대될 것임을 보여줍니다. 이러한 용도를 활용함으로써 이해관계자들은 혁신을 촉진하고 다양한 분야의 진단을 강화할 수 있습니다.

맞춤형 분석법 개발 시장 성장 촉진요인 및 과제

맞춤형 분석법 개발 시장은 기술, 경제, 규제 등 여러 가지 역동적인 요인의 영향을 받고 있으며, 이는 이해관계자들에게 기회이자 도전이 될 수 있습니다.

맞춤형 분석법 개발 시장을 촉진하는 요인은 다음과 같습니다.

• 기술 개발: 기술 개발: 신제품의 지속적인 도입, 특히 산업 자동화 및 다중화를 특징으로 하는 분석 기술이 시장 성장에 크게 기여하고 있습니다. 이러한 발전은 분석의 유효성을 높이고 진단 및 연구 활용의 질을 향상시킵니다.
• 표적 치료 시스템에 대한 수요 증가: 환자 중심 의료로의 전환은 특정 맞춤형 분석 서비스에 대한 수요를 뒷받침하고 있습니다. 이러한 발전은 더 나은 표적 치료 접근법을 가능하게 하고, 환자 결과를 개선하며, 시장 성장을 견인할 것입니다.
• R&D 투자 확대: R&D, 특히 생명공학 및 의료 분야에 대한 투자 증가가 맞춤형 분석 시장을 견인하고 있습니다. 이러한 자금 지원은 창의성을 촉진하고, 더 우수하고 빠른 분석법 개발을 촉진합니다.
• 지원 정책: 규제 조항이 확대됨에 따라 맞춤형 분석의 승인 절차가 점점 더 쉬워지고 있습니다. 연구 및 진단 이해관계자들은 개념의 구현을 장려하고 새로운 진단 약품의 빠른 시장 진입을 촉진하고 있습니다.
• 국제 보건 이니셔티브: 전 세계 보건 개선에 대한 노력으로 인해 정확하고 시기적절한 진단에 대한 수요가 증가하고 있습니다. 맞춤형 분석은 공중 보건 개선에 중요한 역할을 하기 때문에 시장 규모가 확대되고 있습니다.

맞춤형 분석법 개발 시장의 과제는 다음과 같습니다.

• 높은 개발 비용: 맞춤형 분석법 개발은 특히 중소기업의 경우 비용이 많이 듭니다. 이러한 경제적 장벽은 신기술의 이점을 제한하고 일부 기업 시장 진입을 제한할 수 있습니다.
• 복잡한 규제 상황: 분석법 개발 프로세스는 규제 요건으로 인해 복잡해지기 쉽습니다. 지역에 따라 규제가 엄격하고 복잡하기 때문에 제품 출시까지 시간이 오래 걸릴 수 있습니다.
• 시장 경쟁: 맞춤형 분석 서비스 시장은 매우 세분화되어 있으며, 다양한 기업들이 시장 점유율을 놓고 경쟁하고 있습니다. 이러한 경쟁은 비용을 상승시키고, 경쟁력을 유지하기 위해서는 최신 연구가 필요합니다.

요약: 맞춤형 분석법 개발 시장은 이러한 시장 성장 촉진요인과 과제의 조합에 의해 주도되고 형성되고 있습니다. 이해관계자들은 이러한 경쟁 환경 속에서 기회를 활용하고 장애물을 최소화할 수 있는 전략을 수립하는 것이 매우 중요합니다.

목차

제1장 주요 요약

제2장 세계의 맞춤형 어세이 개발 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 맞춤형 어세이 개발 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 맞춤형 어세이 개발 시장 : 유형별
  • 어세이 개발
  • 어세이 최적화
  • 어세이 변환
  • 신규 분석 대상물 개발
  • 커스텀 커플링
  • 커스텀 활용
  • 시료 시험
  • 기타
• 세계의 맞춤형 어세이 개발 시장 : 용도별
  • 의료
  • 생물학
  • 환경
  • 학술
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 맞춤형 어세이 개발 시장 : 지역별
• 북미의 맞춤형 어세이 개발 시장
• 유럽의 맞춤형 어세이 개발 시장
• 아시아태평양의 맞춤형 어세이 개발 시장
• 기타 지역의 맞춤형 어세이 개발 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 맞춤형 어세이 개발 시장 성장 기회 : 유형별
  • 세계의 맞춤형 어세이 개발 시장 성장 기회 : 용도별
  • 세계의 맞춤형 어세이 개발 시장 성장 기회 : 지역별
• 세계의 맞춤형 어세이 개발 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 맞춤형 어세이 개발 시장 생산능력 확대
  • 세계의 맞춤형 어세이 개발 시장 기업인수합병(M&A), 합병사업
  • 인증 및 라이선싱

제7장 주요 기업 개요

• 2BScientific
• PerkinElmer
• Eurofins Discovery
• Thermos Fisher Scientific
• Creative Biolabs
• PlexBio
• Gyros Protein Technologies
• Mission Bio
• Sygnature Discovery
• AssayGate

영문목차

The future of the global custom assay development market looks promising, with opportunities in the medicine, biology, environment, and academic markets. The global custom assay development market is expected to grow with a CAGR of 7.7% from 2025 to 2031. The major drivers for this market are increasing demand for personalized medicine and targeted therapies and ongoing advancement in biomarker discovery and validation.

• Lucintel forecasts that, within the type category, assay development is expected to witness the highest growth over the forecast period.
• Within the application category, medicine is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Custom Assay Development Market

The custom assay development market is expanding while undergoing many changes due to the emergence of several trends. These trends reveal the market positioning and potential areas for development.

• Personalized Medicines Offer New Opportunities for Diagnostic Companies: The growth of personalized medicine is increasing the need for custom assays tailored to individual patient profiles. This situation attracts more complex diagnostics and therapies, which benefits patients and contributes to the overall progress of healthcare interventions.
• Addition of Artificial Intelligence and Automation: The use of artificial intelligence and simultaneous automation in the development of assays is increasing effectiveness and accuracy. These technologies optimize the design phase, minimize errors, and expedite the development of complex assays for new diagnostics.
• Growth of Multiplex Assays: Multiplex assays are transforming the market by enabling the simultaneous detection of several targets, thereby increasing the scope of diagnostics. This trend improves testing efficiency and conserves resources, which is advantageous in both clinical and research settings.
• Initiatives to Streamline Approvals for Custom Assays: More countries are adopting new regulations that simplify the approval process for custom assays, making standards more comprehensible for developers. This encouragement fosters new ideas and financial support for developing new assays, aiding market growth.
• Rising Significance of Point-of-Care Testing: The increasing demand for diagnostic procedures in doctors' offices or laboratories is driving advancements in custom assays. Innovations allow for timely diagnostics, enhancing the dynamics of change in a medically oriented healthcare system and promoting decentralization.

Such trends are being integrated into the custom assay development market to foster innovation, enhance efficiency, and, most importantly, provide personalized healthcare solutions.

Recent Developments in the Custom Assay Development Market

There have also been substantive developments in the custom assay development market stemming from technological advancements and strategic initiatives to improve testing accuracy and applicability.

• Advanced Multiplexing Technologies: Advanced multiplexing technologies enable the use of the same assay for the simultaneous measurement of various biomarkers. This marks a significant step towards improving research, clinical diagnostics, and decision-making, particularly in patient management.
• AI-Driven Assay Design: The assay design process is undergoing a revolution, largely due to the role of artificial intelligence. Understanding and simulating optimal assay conditions are part of AI algorithms that facilitate a more efficient test development process, allowing for quick dispensing of necessary test results in the medical field.
• Collaboration Initiatives: Partnerships and collaborations between biotech companies and research institutions are on the rise, helping to drive innovation in the study and development of assays. Such collaborations enhance resource sharing and aid in developing advanced assays that bring research closer to practical application.
• Growth in Emerging Countries: The development of custom assay services is rapidly expanding in less developed regions, especially in Asia. Local players are providing relevant and affordable products, increasing the market for diagnostics.
• Regulatory Improvements: New structured guidelines are opening doors for easier approval of custom assays. This development attracts relevant stakeholders to the field, promoting the creation of new strategies for assays.

These developments are changing the landscape of custom assay development by improving the quality and efficiency of testing solutions, ultimately leading to better healthcare systems.

Strategic Growth Opportunities for Custom Assay Development Market

A wide array of applications in the custom assay development market presents several strategic growth opportunities, primarily due to technological advancements and evolving healthcare demands.

• Assays for Genomics and Proteomics: There is a growing need for custom-made genomic and proteomic assays across various research and clinical areas. Creating assays that can profile complex biological samples will enhance the understanding of disease mechanisms and facilitate personalized therapies.
• Diagnosing Infectious Diseases: The high burden of infectious diseases necessitates the development of rapid diagnostic testing and custom-assayed systems. Focusing on infectious disease diagnostics benefits public health and individual patients in many healthcare systems.
• Pharmaceutical Outcomes: The emphasis on personalized medicine is driving growth potential for companion diagnostics. These specialized assays help determine how a patient will respond to specific therapies, aiding in better planning and effectiveness of treatments.
• Environmental Assays: The custom assay market is diversifying with the trend of environmental testing, where dermal and blood assays are used to detect toxins and pathogens. Addressing pollution through these assays promotes public health and compliance with health legislation.
• Point-of-Care Assays: The demand for point-of-care custom assays is rising due to the increasing need for extensive point-of-care solutions. Providing simple and cost-effective point-of-care alternatives will reduce patients' discomfort in accessing timely tests and improve healthcare service quality.

These growth opportunities indicate that the custom assay services market will expand significantly. By leveraging these applications, stakeholders can foster innovation and enhance diagnostics across various fields.

Custom Assay Development Market Driver and Challenges

The custom assay development market is influenced by several dynamic factors, including technological, economic, and regulatory aspects, which present both opportunities and challenges for stakeholders.

The factors driving the custom assay development market include:

• Technology Development: The continuous introduction of new products, especially assay technologies featuring industrial automation and multiplexing, has significantly contributed to market growth. These advancements enhance assay effectiveness and improve the quality of diagnostics and research utilization.
• Increase in Demand for Targeted Therapeutic Systems: The shift toward patient-centered care sustains the demand for specific custom assay services. This development enables better and more targeted treatment approaches, resulting in improved patient outcomes and market growth.
• Expansion of R&D Spending: Increased investment in research and development, particularly in biotechnology and healthcare, is boosting the custom assay market. This funding fosters creativity and the creation of better and faster assays.
• Supporting Policies: Widening regulatory provisions are making the approval process for custom assays increasingly straightforward. Stakeholders in research and diagnostics are encouraged to implement their concepts, facilitating quicker market entry for new diagnostics.
• Global Health Initiatives: Efforts to improve global health are increasing the demand for accurate and timely diagnostics. Custom assays play a crucial role in enhancing public health, thus expanding the market scope.

Challenges in the custom assay development market include:

• Unaffordable Development Costs: Developing custom assays can be particularly expensive for small and medium enterprises. These financial barriers may limit the advantages of new technologies and restrict market entry for some companies.
• Complex Regulatory Landscape: The process of developing assays can be cumbersome due to regulatory requirements. Stringent and convoluted rules in some regions can lengthen the time to market for products.
• Market Competition: The custom assay service market is highly fragmented, with various players competing for market share. This competition drives costs and necessitates up-to-date research to maintain a competitive edge.

In summary, the custom assay development market is driven and shaped by a combination of these drivers and challenges. It is crucial for stakeholders to devise strategies that capitalize on opportunities and minimize obstacles to advance in this competitive landscape.

List of Custom Assay Development Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, custom assay development companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the custom assay development companies profiled in this report include-

• 2BScientific
• PerkinElmer
• Eurofins Discovery
• Thermos Fisher Scientific
• Creative Biolabs
• PlexBio
• Gyros Protein Technologies
• Mission Bio
• Sygnature Discovery
• AssayGate

Custom Assay Development by Segment

The study includes a forecast for the global custom assay development market by type, application, and region.

Custom Assay Development Market by Type [Analysis by Value from 2019 to 2031]:

• Assay Development
• Assay Optimization
• Assay Conversion
• New Analyte Development
• Custom Coupling
• Custom Conjugation
• Sample Testing
• Others

Custom Assay Development Market by Application [Analysis by Value from 2019 to 2031]:

• Medicine
• Biology
• Environment
• Academic
• Others

Custom Assay Development Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Custom Assay Development Market

The market for developing specialized tests is constantly witnessing innovations, driven by technological advancements and an increasing need for customized diagnostic tools. The improvements in assay technology and a growing focus on personalized medicine are enabling the execution of better and more accurate tests in the healthcare and pharmaceutical industries. Here is a summary of recent developments in the United States, Chinese, German, Indian, and Japanese markets.

• United States: The custom assay market is experiencing significant expansion due to advances in multiplex assays and the rise of rapid testing methods. Firms are strategically positioning themselves in the personalized medicine segment, leading to a growing number of requests for assay development. Collaborative research between biotech companies and universities is enhancing research capabilities and accelerating development.
• China: There is increasing demand for custom assay development services in China, particularly in the fields of genomics and proteomics. Government investments in the health industry and biotechnology are fostering innovative development. Additionally, local companies are increasingly internationalizing the market by offering competitive rates and tailored solutions.
• Germany: Germany is a leading country in Europe, capturing a substantial market share in custom assay services. High-throughput screening technologies are becoming more prevalent in assay development processes. The incorporation of automation and artificial intelligence in biostatistics and biotechnologies is enabling researchers to enhance the sophistication of assay design for drug discovery and diagnosis.
• India: While a formal custom assay market is still emerging, India is currently experiencing a trend toward this sector due to rising demand for affordable diagnostic solutions. Advances in new technologies have empowered startups to produce cost-effective assays, particularly for infectious diseases. Collaborations with research organizations are further driving innovation in assay development.
• Japan: Japan is making significant strides in the technological advancement of custom assay activities. Increasing partnerships between industry and academic/community institutions are facilitating the introduction of more advanced and specific assays, essential for precision medicine and targeted therapy approaches.

Features of the Global Custom Assay Development Market

Market Size Estimates: Custom assay development market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Custom assay development market size by type, application, and region in terms of value ($B).

Regional Analysis: Custom assay development market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the custom assay development market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the custom assay development market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the custom assay development market by type (assay development, assay optimization, assay conversion, new analyte development, custom coupling, custom conjugation, sample testing, and others), application (medicine, biology, environment, academic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Custom Assay Development Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Custom Assay Development Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Custom Assay Development Market by Type
  • 3.3.1: Assay Development
  • 3.3.2: Assay Optimization
  • 3.3.3: Assay Conversion
  • 3.3.4: New Analyte Development
  • 3.3.5: Custom Coupling
  • 3.3.6: Custom Conjugation
  • 3.3.7: Sample Testing
  • 3.3.8: Others
• 3.4: Global Custom Assay Development Market by Application
  • 3.4.1: Medicine
  • 3.4.2: Biology
  • 3.4.3: Environment
  • 3.4.4: Academic
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Custom Assay Development Market by Region
• 4.2: North American Custom Assay Development Market
  • 4.2.1: North American Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.2.2: North American Market by Application: Medicine, Biology, Environment, Academic, and Others
• 4.3: European Custom Assay Development Market
  • 4.3.1: European Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.3.2: European Market by Application: Medicine, Biology, Environment, Academic, and Others
• 4.4: APAC Custom Assay Development Market
  • 4.4.1: APAC Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.4.2: APAC Market by Application: Medicine, Biology, Environment, Academic, and Others
• 4.5: ROW Custom Assay Development Market
  • 4.5.1: ROW Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.5.2: ROW Market by Application: Medicine, Biology, Environment, Academic, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Custom Assay Development Market by Type
  • 6.1.2: Growth Opportunities for the Global Custom Assay Development Market by Application
  • 6.1.3: Growth Opportunities for the Global Custom Assay Development Market by Region
• 6.2: Emerging Trends in the Global Custom Assay Development Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Custom Assay Development Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Custom Assay Development Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: 2BScientific
• 7.2: PerkinElmer
• 7.3: Eurofins Discovery
• 7.4: Thermos Fisher Scientific
• 7.5: Creative Biolabs
• 7.6: PlexBio
• 7.7: Gyros Protein Technologies
• 7.8: Mission Bio
• 7.9: Sygnature Discovery
• 7.10: AssayGate